AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9360661
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg intravenous iron once weekly
Trial: 9360661
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg intravenous iron twice weekly
Trial: 7505159
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of detailed written information and anxiety management training
Trial: 26847970
Drug: Optimal medical
RxNorm normalized name: Optima Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal medical treatment alone (control)
Trial: 23446198
Drug: Antipsychotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotic treatment (specific medication not mentioned)
Trial: 20606083
Drug: Lapatinib (1,500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lapatinib (1,500 mg once daily)
Trial: 20606083
Drug: Lapatinib plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lapatinib plus Pazopanib (1,000 mg plus 400 mg once daily or 1,500 mg plus 800 mg once daily)
Trial: 15867239
Drug: 17AAG (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17AAG (10 to 395 mg/m2)
Trial: 15867239
Drug: 17AAG (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17AAG (10 to 295 mg/m2)
Trial: 12362100
Drug: EUBT with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EUBT with 100 mg of (13)C-urea
Trial: 12362100
Drug: EUBT with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EUBT with 50 mg of (13)C-urea
Trial: 12362100
Drug: EUBT with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EUBT with 25 mg of (13)C-urea
Trial: 7838898
Drug: Alprazolam therapy
RxNorm normalized name: Alprazolam
DrugBank: Alprazolam (DB00404)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alprazolam therapy (2-2.5 mg for 30 days)
Trial: 1707298
Drug: GM-CSF (75,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GM-CSF (75, 150, 300, or 600 micrograms protein/day, administered SC twice a day for 5 days)
Trial: 31939363
Drug: SRP +
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SRP + Photodynamic therapy (using Indocyanine green)
Trial: 19583878
Drug: Dark chocolate
RxNorm normalized name: Ensure Original Dark Chocolate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dark chocolate (50 g daily dose with 70% cocoa containing 750 mg polyphenols)
Trial: 19583878
Drug: Tomato extract
RxNorm normalized name: TOMATO EXTRACT CONTAINING LYCOPENE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tomato extract (one capsule containing 15 mg lycopene per day)
Trial: 21999489
Drug: Escitalopram (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram (10 mg)
Trial: 11284758
Drug: Topical Ketorolac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Ketorolac trometamol 0.5% ophthalmic solution
Trial: 8190431
Drug: Strict control
RxNorm normalized name: Euphrasia stricta extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strict control (n=68): fasting blood glucose < 4.44 mmol/L and postprandial blood glucose < 6.66 mmol/L
Trial: 8190431
Drug: Customary control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Customary control (n=69): fasting blood glucose < 5.55 mmol/L and postprandial blood glucose < 7.77 mmol/L
Trial: 30476251
Drug: Atorvastatin (starting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (starting dose 80 mg PO daily)
Trial: 28345432
Drug: Sildenafil citrate,
RxNorm normalized name: Sildenafil Citrate, 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil citrate, 50 mg
Trial: 20442354
Drug: Finasteride 1
RxNorm normalized name: finasteride 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride 1 mg orally daily
Trial: 9933794
Drug: 60 mg/day
RxNorm normalized name: cabozantinib s-malate 60 mg/day (20 mg x 3/day) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg/day of urapidil for 4 weeks
Trial: 9843009
Drug: 0.05% retinoic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% retinoic acid cream
Trial: 25123060
Drug: DHA-O (2.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA-O (2.4 g/day DHA and EPA in a 2.7:1 ratio)
Trial: 25123060
Drug: Fish Oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish Oil (FO; 2.0 g/day DHA and EPA in a 0.7:1 ratio)
Trial: 17324401
Drug: Capsule Endoscopy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsule Endoscopy (CE)
Trial: 16760508
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (1 mg/d)
Trial: 17377120
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg dexamethasone IV
Trial: 26370724
Drug: 2 mL
RxNorm normalized name: ethanol 2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mL saline
Trial: 9588451
Drug: Insulin response
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin response to a 75‐g oral glucose load in nonrelatives
Trial: 9588451
Drug: Insulin response
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin response to a 75‐g oral glucose load in relatives
Trial: 9588451
Drug: Multivariate analysis
RxNorm normalized name: Chemicals and reagents for analysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multivariate analysis for insulin response in nonrelatives
Trial: 9588451
Drug: Multivariate analysis
RxNorm normalized name: Chemicals and reagents for analysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multivariate analysis for insulin response in relatives
Trial: 7979639
Drug: Propranolol 160
RxNorm normalized name: propranolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 160 mg LA
Trial: 2609241
Drug: PGE1 (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGE1 (60 micrograms i.v. infusion daily for 3 weeks)
Trial: 2609241
Drug: Naftidrofuryl (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naftidrofuryl (600 mg daily for 3 weeks)
Trial: 27469294
Drug: Short dental
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short dental implants (6-8 mm)
Trial: 27469294
Drug: Long dental
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long dental implants (11 mm)
Trial: 12777590
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (other antibiotics)
Trial: 10711911
Drug: Risperidone (4-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (4-10 mg)
Trial: 10711911
Drug: Haloperidol (5-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (5-20 mg)
Trial: 3919555
Drug: bepridil (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bepridil (400 mg once a day)
Trial: 31169354
Drug: Silicone gel
RxNorm normalized name: SILTREX Silicone Gel-Pad
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silicone gel (Stratacel®; Stratpharma) applied twice a day for 7 days
Trial: 31169354
Drug: Petrolatum-based ointment
RxNorm normalized name: PETROLATUM BASE
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Petrolatum-based ointment applied twice a day for 7 days
Trial: 29431785
Drug: Glucono‐delta‐lactone (GDL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucono‐delta‐lactone (GDL) 2000 mg day‐1
Trial: 27352486
Drug: Body acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Body acupuncture and conventional western medication (both groups)
Trial: 22013100
Drug: Intensive insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive insulin therapy targeting normoglycemia (80‐110 mg/dl)
Trial: 22013100
Drug: Tolerating hyperglycemia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolerating hyperglycemia up to 215 mg/dl
Trial: 17728050
Drug: Sildenafil as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil as monotherapy
Trial: 17728050
Drug: Sildenafil in
RxNorm normalized name: sildenafil Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil in combination with SSRI (paroxetine)
Trial: 28027198
Drug: Topical anesthetics
RxNorm normalized name: topical anesthetics (obsolete)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anesthetics
Trial: 15914256
Drug: Standardized physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized physical therapy plus 4 music therapy sessions
Trial: 15914256
Drug: Standardized physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized physical therapy alone
Trial: 10768630
Drug: Intravenous methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous methylprednisolone sodium succinate treatment
Trial: 8829312
Drug: Melatonin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (40 mg/day orally in the evening, starting 7 days prior to cytokine injection)
Trial: 8829312
Drug: Cytokine alone
RxNorm normalized name: cytosine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytokine alone (IL-2: 3 x 10(6) IU/day s.c. every day, 6 days/week for 4 weeks; TNF: 0.75 mg/day i.v. for 5 days)
Trial: 1313875
Drug: 4.1 g
RxNorm normalized name: psyllium 4.1 GM Powder for Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.1 g daily fibre supplementation
Trial: 3881913
Drug: Long-term Verapamil
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term Verapamil therapy
Trial: 31344685
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 5000 IU daily
Trial: 29901760
Drug: Leucine (LEU;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leucine (LEU; 10 g milk protein with 3 g total l-leucine)
Trial: 29901760
Drug: Whey Protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey Protein Isolate (WPI; 25 g WPI with 3 g l-leucine)
Trial: 19960492
Drug: Citalopram (CIT)
DrugBank: Citalopram (DB00215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Citalopram (CIT) with dose escalation (20-60 mg/day)
Trial: 12891211
Drug: 3.5 g
RxNorm normalized name: Calcium 760 MG/3.5 GM Oral Granule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.5 g of fish oil daily for 12 weeks
Trial: 12891211
Drug: Placebo oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo oil daily for 12 weeks
Trial: 10684161
Drug: Ferrous fumarate
RxNorm normalized name: Ferrous Fumarate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous fumarate (60 mg elemental Fe) daily
Trial: 10684161
Drug: Ferrous fumarate
RxNorm normalized name: Ferrous Fumarate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous fumarate (60 mg elemental Fe) intermittently (three times a week)
Trial: 30217371
Drug: AZL-M 80
RxNorm normalized name: M
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZL-M 80 mg
Trial: 30217371
Drug: AZL-M/CLD 40/25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZL-M/CLD 40/25 mg
Trial: 30217371
Drug: AZL-M/CLD 80/25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZL-M/CLD 80/25 mg
Trial: 27169436
Drug: Community exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community exercise program (year-long, at least twice per week, supervised by a case manager)
Trial: 22659765
Drug: Topical gentamicin-collagen
RxNorm normalized name: gentamicin Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical gentamicin-collagen sponge plus standard of care
Trial: 17584482
Drug: Methylprednisolone (MP)
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (MP) in the priming solution
Trial: 15805350
Drug: Comprehensive regional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive regional hospital-based parent education program about violent infant shaking, administered at the time of the child's birth.
Trial: 9871429
Drug: Rifampin 600
RxNorm normalized name: rifampin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin 600 mg orally once a day for 5 days, followed by 80 mg tamoxifen on the sixth day.
Trial: 9871429
Drug: Rifampin 600
RxNorm normalized name: rifampin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin 600 mg orally once a day for 5 days, followed by 120 mg toremifene on the sixth day.
Trial: 7610930
Drug: Oral 1,25(OH)2D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral 1,25(OH)2D (Rocaltrol) 0.5 microgram twice a day for 5 days
Trial: 2694180
Drug: arbaprostil 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: arbaprostil 10 mcg
Trial: 2694180
Drug: arbaprostil 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: arbaprostil 25 mcg
Trial: 2694180
Drug: arbaprostil 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: arbaprostil 50 mcg
Trial: 2694180
Drug: arbaprostil 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: arbaprostil 400 mcg
Trial: 2694180
Drug: arbaprostil 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: arbaprostil 1200 mcg
Trial: 2694180
Drug: arbaprostil 1600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: arbaprostil 1600 mcg
Trial: 21893693
Drug: Melatonin (MEL)
DrugBank: Melatonin (DB01065)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Melatonin (MEL) 5 mg daily at bedtime
Trial: 14557857
Drug: Bolus-titrated therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus-titrated therapy (flunitrazepam, clonidine, haloperidol adjusted as needed)
Trial: 14557857
Drug: Infusion-titrated therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion-titrated therapy (continuous infusion of flunitrazepam, clonidine, haloperidol)
Trial: 8268342
Drug: Halofantrine (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Halofantrine (500 mg daily for 3 days)
Trial: 8268342
Drug: Halofantrine (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Halofantrine (500 mg daily for 6 days)
Trial: 8268342
Drug: Chloroquine (total
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine (total dose of 1,500 mg over 3 days)
Trial: 17012871
Drug: Licensed vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Licensed vaccine (DTaP-IPV//PRP-T)
Trial: 10447904
Drug: Remifentanil infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil infusion in conjunction with epidural ropivacaine and isoflurane anaesthesia
Trial: 28215665
Drug: 1 year
RxNorm normalized name: COVID vacc 2024-2025 (5-11 years) (Pfizer)/PF 10 mcg/0.3 mL INTRAMUSC VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 year of trastuzumab (8 mg/kg IV once, then 6 mg/kg every 3 weeks)
Trial: 28215665
Drug: 2 years
RxNorm normalized name: Childrens Panadol 5 - 12 Years
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 years of trastuzumab (8 mg/kg IV once, then 6 mg/kg every 3 weeks)
Trial: 26284747
Drug: Control (Glasses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Glasses Prescriptions Only)
Trial: 16580575
Drug: Extended-release metoprolol
RxNorm normalized name: metoprolol Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release metoprolol succinate (25, 100, or 400 mg)
Trial: 16580575
Drug: Extended-release felodipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release felodipine (2.5, 10, or 20 mg)
Trial: 16580575
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of extended-release metoprolol succinate and extended-release felodipine (various combinations)
Trial: 16580575
Drug: Low-dose combination
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose combination (ER metoprolol succinate 25 mg/ER felodipine 2.5 mg)
Trial: 10669338
Drug: HIV human
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: HIV human hyperimmune immunoglobulin (HIVIG) 200 mg/kg
Trial: 10669338
Drug: HIV human
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: HIV human hyperimmune immunoglobulin (HIVIG) 400 mg/kg
Trial: 10669338
Drug: HIV human
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: HIV human hyperimmune immunoglobulin (HIVIG) 800 mg/kg
Trial: 1593359
Drug: Furosemide (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (1 mg/kg per dose) intravenously every 24 hours for five doses
Trial: 1593359
Drug: Furosemide (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (1 mg/kg per dose) with metolazone (0.2 mg/kg per dose) enterally with doses 3 and 4 of furosemide
Trial: 1593359
Drug: Metolazone (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metolazone (0.2 mg/kg per dose) enterally every 24 hours for five doses
Trial: 22450530
Drug: 400 ml
RxNorm normalized name: Lantidra 400 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 ml of oral 12.5% carbohydrate solution
Trial: 18690345
Drug: Estradiol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estradiol (2 mg) + trimegestone (0.5 mg)
Trial: 18690345
Drug: Estradiol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estradiol (2 mg) + dydrogesterone (10 mg)
Trial: 1111446
Drug: Prophylactic heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic heparin or aspirin
Trial: 28806217
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg intravenous ondansetron
Trial: 22330131
Drug: HCl infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: HCl infusion (0.15 M for 30 minutes)
Trial: 18827611
Drug: Oral plus
RxNorm normalized name: Acetaminophen/Dexbrompheniramine Maleate/Pseudoephedrine Hydrochloride 500 MG-3 MG-60 MG Oral Tablet, Extended Release [DRIXORAL PLUS]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral plus written information
Trial: 11179942
Drug: Oral information
RxNorm normalized name: Inflammation OTC Bruise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral information only
Trial: 15927054
Drug: Functional Assessment
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Functional Assessment of Cancer Therapy‐‐General
Trial: 15927054
Drug: European Organization
FDA approved: no
EMA approved: no
PMDA approved: no
Description: European Organization for the Research and Treatment of Cancer Core Quality of Life Questionnaire
Trial: 9538308
Drug: Metoprolol CR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol CR (100 mg once daily)
Trial: 27605629
Drug: ISIS 388626
RxNorm normalized name: ISIS-APOCIII-LRX
DrugBank: Olezarsen (DB18728)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ISIS 388626 (200 mg)
Trial: 27605629
Drug: ISIS 388626
RxNorm normalized name: ISIS-APOCIII-LRX
DrugBank: Olezarsen (DB18728)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ISIS 388626 (100 mg)
Trial: 21239075
Drug: High-dose clopidogrel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose clopidogrel (150 mg/day for 1 month)
Trial: 21239075
Drug: Standard-dose clopidogrel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose clopidogrel (75 mg/day for 1 month)
Trial: 21239075
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (75 mg/day for 1 month)
Trial: 26876716
Drug: CCR4 antagonist
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: CCR4 antagonist
Trial: 18719447
Drug: Morphine patient‐controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine patient‐controlled analgesia
Trial: 16115358
Drug: CLA-enriched dairy
RxNorm normalized name: Beano Dairy Defense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CLA-enriched dairy products (1.43 g c9,t11 CLA/d; 4.71 g tVA/d)
Trial: 16115358
Drug: Control dairy
RxNorm normalized name: Beano Dairy Defense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control dairy products (0.17 g c9,t11 CLA/d; 0.31 g tVA/d)
Trial: 10051075
Drug: Prone position
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prone position with inhaled nitric oxide (10 ppm)
Trial: 10051075
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of nitric oxide (10 ppm) in supine position
Trial: 10051075
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of prone position and inhaled nitric oxide
Trial: 31807849
Drug: Drug-eluting stents
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-eluting stents (DES) with paclitaxel
Trial: 21251129
Drug: Moxifloxacin (positive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin (positive control drug)